Methyl (S) -2- (Boc-amino) -3- [(S) -2-oxo-3-pyrrolidinyl] propanoate CAS 328086-60-8 PF-07321332 Boceprevir Intermediate
Ipese Iṣowo PF-07321332 Awọn agbedemeji ti o jọmọ Paxlovid pẹlu Didara Giga
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S) -2- (Boc-amino) -3- [(S) -2-oxo-3-pyrrolidinyl] propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0] hexane CAS 943516-54-9
Orukọ Kemikali | Methyl (S)-2- (Boc-amino) -3- [(S) -2-oxo-3-pyrrolidinyl] propanoate |
Awọn itumọ ọrọ sisọ | Methyl (S) -2- ((tert-butoxycarbonyl) amino) -3- ((S) -2-oxopyrrolidin-3-yl) propanoate;(αS,3S) -α- [(tert-Butyloxycarbonyl) aMino] -2-oxo-3-pyrrolidinepropanoic acid Methyl Ester;(S) -Methyl 2- ((tert-butoxycarbonyl) amino) -3- ((S) -2-oxopyrrolidin-3-yl) propanoate. |
Nọmba CAS | 328086-60-8 |
NỌMBA CAT | RF-PI317 |
Iṣura Ipo | Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn ọgọọgọrun Kilogram |
Fọọmu Molecular | C13H22N2O5 |
Òṣuwọn Molikula | 286.33 |
Brand | Ruifu Kemikali |
Nkan | Awọn pato |
Ifarahan | Funfun to Pa-White Powder |
Idanimọ A | IR: Iru si nkan Itọkasi |
Idanimọ B | Akoko Idaduro: Iru si nkan Itọkasi |
Pipadanu lori Gbigbe | ≤1.0% |
Aloku lori Iginisonu | ≤0.20% |
Aimọ Kanṣoṣo | ≤0.50% |
Lapapọ Awọn Aimọ | ≤2.0% |
Awọn Irin Eru (Pb) | ≤20ppm |
Mimo | ≥98.0% |
Igbeyewo Standard | Standard Enterprise |
Lilo | Agbedemeji ti PF-07321332 Paxlovid (CAS 2628280-40-8) ati Boceprevir (CAS 394730-60-0) |
Package: Igo, apo apamọwọ Aluminiomu, ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin ati kokoro infestation.
Methyl (S) -2- (Boc-amino) -3- [(S) -2-oxo-3-pyrrolidinyl] propanoate (CAS 328086-60-8) jẹ agbedemeji ti PF-07321332 Paxlovid (CAS 2628280-40). -8) ati Boceprevir (CAS 394730-60-0).PF-07321332, paati bọtini ti Paxlovid (PF-07321332 ati Ritonavir) eyiti o jẹ iwadii COVID-19 ti o jẹ oludije antiviral oral, jẹ inhibitor 3C-like protease (3CLPRO) ti ẹnu pẹlu awọn ipa antiviral ti o lagbara lodi si ọlọjẹ SARS-CoV-2 ati COVID-19.Ni Oṣu kọkanla ọjọ 6th, ọdun 2021, Pfizer kede pe Paxlovid dinku ni pataki ile-iwosan ati iku, da lori itupalẹ igba diẹ ti Alakoso 2/3 EPIC-HR (Iyẹwo ti Inhibition Protease fun COVID-19 ni Awọn Alaisan Ewu Giga) laileto, iwadii afọju meji ti awọn alaisan agbalagba ti kii ṣe ile-iwosan pẹlu COVID-19, ti o wa ninu eewu giga ti lilọsiwaju si aisan nla.Boceprevir (EBP-520) jẹ inhibitor protease HCV (Ki=14 nM) fun itọju ikolu arun jedojedo C.Boceprevir pẹlu pegylated interferon ati ribavirin (PegIFN/RBV) jẹ ki ilọsiwaju ni awọn oṣuwọn esi ti ọlọjẹ ti o tẹsiwaju ti awọn alaisan pẹlu genotype 1 HCV.Boceprevir ṣe ajọṣepọ pẹlu itọju ajẹsara ajẹsara (IT) nipa didi cytochrome P450 3A enzymu.